查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916946

一次性可伸縮安全注射器市場（按材料、類型、容量、通路和最終用戶分類）—2026-2032年全球預測

Retractable Safety Syringe for Single Use Market by Material, Type, Capacity, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，一次性可伸縮安全注射器市場價值將達到 35.4 億美元，到 2026 年將成長至 38.7 億美元，到 2032 年將達到 67.8 億美元，複合年成長率為 9.72%。

關鍵市場統計數據
基準年 2025 35.4億美元
預計年份：2026年 38.7億美元
預測年份 2032 67.8億美元
複合年成長率 (%) 9.72%

了解為什麼採用可伸縮一次性安全注射器是提高臨床安全性、確保合規性和增強供應鏈韌性的策略要務。

可伸縮一次性安全注射器已成為提高病人安全、保護醫護人員、加強所有醫療機構感染控制通訊協定的關鍵工具。近年來，機械設計、材料科學和以用戶為中心的人體工學方面的創新加速了從傳統器械向工程化安全解決方案的轉變，這些解決方案降低了針刺傷的風險，並有助於滿足更嚴格的監管要求。

識別正在重塑可伸縮安全注射器市場的變革性變化，包括監管壓力、技術融合和採購趨勢。

可伸縮安全注射器的市場環境正經歷多重因素的交會變化，這些變化正在重塑產品需求和採購行為。監管機構日益重視醫療設備的安全性和可追溯性，迫使製造商整合被動和主動安全機制，以最大限度地減少對業務流程的影響，同時滿足各種合規標準。同時，醫院系統和大型門診網路正將醫護人員防護指標作為核心品質指標，從而有力地推動了對能夠降低職業暴露風險的醫療器材的採用。

評估2025年美國關稅對伸縮安全注射器的採購、成本結構和全球供應鏈風險的累積影響

2025年美國關稅政策對醫療設備（包括可伸縮安全注射器）的全球籌資策略和成本結構造成了顯著壓力。依賴跨境零件分銷的製造商和經銷商被迫重新評估其供應商組合、製造地和定價策略，以維持利潤率並履行對醫療系統的合約義務。為此，許多機構加快了近岸外包的步伐，透過在免稅地區尋找替代供應商來降低風險。

關鍵細分市場分析重點在於材料、類型、通路、最終用戶和產能等趨勢對產品設計和分銷管道的影響

細分市場分析揭示了影響可伸縮安全注射器設計重點和市場推廣策略的細微產品和商業化路徑。玻璃和塑膠材質的選擇會影響器械重量和使用者感知，以及消毒方法和破損風險。塑膠材質便於經濟高效地成型和實現複雜設計，而當需要特定的穩定性或化學相容性時，玻璃材質可能是更佳選擇。

影響美洲、歐洲、中東和非洲以及亞太地區安全注射器需求和在地化策略的區域趨勢和成長要素

區域趨勢將對法規要求、採購政策以及可伸縮安全注射器的普及率產生重大影響。在美洲，相關人員的關注點集中在職業安全指標、大型綜合醫療衛生系統以及強調循證醫療器材和強力的上市後監管的公共採購框架上。該地區還優先考慮與現有廢棄物管理和銳器處置通訊協定的互通性，並且對能夠最大限度減少訓練時間和操作流程差異的醫療器材表現出濃厚的興趣。

競爭考察及公司層面的洞察，聚焦在領先的伸縮式注射器製造商的策略性舉措、產品系列差異化和夥伴關係模式。

可伸縮安全注射器產業的企業發展趨勢是由多種因素共同驅動的，包括透過機制創新實現差異化、規模經濟以及策略聯盟。主要企業正在投資模組化平台，以支援主動和被動安全機制，從而能夠快速適應客戶偏好和監管要求。能夠展現可重複的生產品質、低缺陷率和強大的上市後監管能力的企業更有可能贏得大規模機構合約和優先供應商地位。

為產業領導者最佳化一次性注射器產品開發、供應鏈、監管和市場推廣策略提供的實用建議

產業領導者應優先考慮一系列協調一致的舉措，以加速產品普及，同時確保供應鏈的穩定性並符合監管要求。首先，應透過投資人體工學研究，檢驗產品在門診、診所、居家照護護理和醫院工作流程中的易用性，使產品開發藍圖與最終用戶的偏好保持一致。設計時注重操作便利性，並儘可能減少額外訓練的負擔，將顯著提高醫護人員和病患的接受度。

報告採用透明的調查方法，解釋資料來源、一手和二手研究、分析架構以及檢驗過程。

本報告的調查方法結合了結構化的初步研究和嚴謹的二次研究綜合，以確保研究結果的平衡性和檢驗。初步研究包括對採購人員、臨床終端使用者、監管專家和生產主管的訪談，以收集關於設備性能、推廣障礙和採購標準的真實世界觀點。此外，還進行了現場考察和設備可用性評估，以將技術觀察結果與臨床工作流程相結合。

結論總結了對相關人員的影響，並概述了促進安全注射器使用和加強營運韌性的當務之急。

本執行摘要整合了可伸縮一次性安全注射器近期發展趨勢的技術、監管、商業性和營運等方面的資訊。相關人員將從本分析中獲得明確的指導，包括：設計工作的重點方向、採購和生產投資的優先順序，以及哪些證據能夠最有效地加速臨床應用和採購部門的推廣。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 一次性可伸縮安全注射器市場（依材料分類）

  • 玻璃
  • 塑膠

9. 一次性可伸縮安全注射器市場（按類型分類）

  • 主動安全注射器
    • 氣動
    • 彈簧型
  • 被動安全注射器
    • 柱塞回縮
    • 鞘套式機構

10. 一次性可伸縮安全注射器市場（以銷售量計）

  • 0.5 ml
  • 1 ml
  • 2 ml
  • 5毫升

第11章 一次性可伸縮安全注射器市場（按分銷管道分類）

  • 醫院藥房
    • 在醫院裡
    • 第三者
  • 線上
    • B2B平台
    • B2C平台
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房

第12章 以最終用戶分類的一次性可伸縮安全注射器市場

  • 門診治療
  • 診所
    • 一般診所
    • 專科診所
  • 居家醫療
  • 醫院
    • 私人的
    • 公共機構

13. 各地區一次性可伸縮安全注射器市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 一次性可伸縮安全注射器市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國一次性可伸縮安全注射器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國一次性可伸縮安全注射器市場

第17章 中國一次性可伸縮安全注射器市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Gerresheimer AG
  • Guangdong Haiou Medical Apparatus Co., Ltd.
  • ICU Medical, Inc.
  • Nipro Corporation
  • Owen Mumford Limited
  • Revolutions Medical Corporation
  • Schott AG
  • Terumo Corporation
  • Ypsomed AG
Product Code: MRR-AE420CB15410

The Retractable Safety Syringe for Single Use Market was valued at USD 3.54 billion in 2025 and is projected to grow to USD 3.87 billion in 2026, with a CAGR of 9.72%, reaching USD 6.78 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.54 billion
Estimated Year [2026] USD 3.87 billion
Forecast Year [2032] USD 6.78 billion
CAGR (%) 9.72%

Introducing the strategic imperative for adoption of retractable single-use safety syringes to drive clinical safety, compliance, and supply resilience

Retractable single-use safety syringes have emerged as a pivotal tool in advancing patient safety, protecting healthcare workers, and strengthening infection control protocols across care settings. Over recent years, innovation in mechanism design, materials science, and user-centric ergonomics has accelerated the transition from legacy devices to engineered safety solutions that reduce needlestick risk and support compliance with stricter regulatory expectations.

This executive summary introduces the thematic drivers, operational implications, and strategic considerations that stakeholders must weigh when evaluating adoption, sourcing, and product development for retractable safety syringes. The analysis emphasizes practical decision points: how device ergonomics impact administration accuracy; how mechanism type influences clinician acceptance and training needs; and how distribution and procurement models shape inventory resilience. By situating technical capabilities alongside care delivery realities, this introduction frames the subsequent sections so that product teams, procurement leaders, and regulatory affairs specialists can rapidly identify priorities.

Transitioning to retractable designs requires coordinated actions across design, clinical validation, and supply chain planning. The following sections explore transformative shifts in regulation and technology, the implications of tariff actions in 2025 on supply networks, segmentation-driven product strategies, regional dynamics, competitive behaviors, and concrete recommendations that support scalable, sustainable deployment of retractable single-use safety syringes across care settings.

Identifying transformative shifts reshaping the retractable safety syringe landscape including regulatory pressure, technological convergence, and procurement dynamics

The landscape for retractable safety syringes is undergoing several convergent shifts that are reshaping product requirements and procurement behavior. Regulatory bodies have increasingly prioritized device safety and traceability, prompting manufacturers to integrate passive and active safety mechanisms that meet diverse compliance thresholds while minimizing workflow disruption. At the same time, hospital systems and large ambulatory networks are elevating health worker protection metrics as a core quality measure, which creates stronger incentives for adopting devices that demonstrably reduce occupational exposure risks.

Technological convergence is another critical shift. Advances in polymer formulation, micro-molding precision, and compact actuation systems have enabled more reliable spring-loaded and air-powered active mechanisms as well as refined passive solutions such as plunger retraction and sheathing mechanisms. These developments improve usability and lower the incidence of deployment errors, which in turn affects training burden and clinician acceptance. Procurement models are also evolving: centralized contracting, value-based purchasing, and an increased preference for supplier transparency are pushing manufacturers to offer lifecycle data and robust post-market surveillance plans.

Finally, the integration of digital health elements and connectivity-enabled supply chain tools is changing how devices are tracked from factory to point of care. Serialization, tamper-evident packaging, and cloud-enabled inventory systems create opportunities for enhanced traceability and recall readiness. Together, these transformative shifts require manufacturers and health systems to adopt a more integrated approach that aligns product innovation with regulatory foresight and procurement realities.

Assessing the cumulative impact of United States tariffs in 2025 on sourcing, cost structures, and global supply chain risk for retractable safety syringes

The United States tariff actions implemented in 2025 introduced measurable pressure on global sourcing strategies and cost structures for medical devices, including retractable safety syringes. Manufacturers and distributors that relied on cross-border component flows had to reassess supplier portfolios, manufacturing footprints, and pricing strategies to preserve margin integrity and contractual commitments to health systems. In response, many organizations accelerated nearshoring initiatives and sought alternative suppliers in tariff-exempt jurisdictions to mitigate exposure.

These policy-driven changes also amplified scrutiny on supply chain visibility. Contracting teams increased demand for multi-tier supplier transparency, insisting on clear documentation of country of origin and sub-component sourcing. As a result, brands that invested early in supply chain traceability and manufacturing flexibility gained negotiating leverage and were better positioned to meet institutional purchasing requirements that now include tariff-related risk covenants.

The tariff environment reinforced the importance of design-for-manufacturing choices that reduce reliance on imported subassemblies and favor materials and processes that can be localized. It also elevated the role of procurement strategy in product adoption decisions; hospitals and large pharmacy chains began incorporating total landed cost scenarios and local sourcing preferences into their tender evaluations. Overall, tariff-related policy shifts in 2025 prompted a strategic reappraisal across R&D, operations, and commercial teams to ensure resilience and cost predictability in the face of evolving trade dynamics.

Key segmentation insights revealing how material, type, distribution channel, end user, and capacity dynamics influence product design and adoption pathways

Segmentation analysis reveals nuanced product and commercial pathways that influence design priorities and go-to-market strategies for retractable safety syringes. Material choices between glass and plastic inform not only device weight and user perception but also sterilization options and breakage risk; plastic enables cost-efficient molding and design complexity, while glass may be preferred for certain stability and chemical compatibility profiles.

Type segmentation differentiates active safety syringes from passive variants, with active devices offering user-actuated protection through air-powered or spring-loaded mechanisms and passive devices relying on built-in safeguards such as plunger retraction or sheathing mechanisms. These differences create distinct requirements for mechanical reliability, regulatory evidence, and clinical training. Distribution channel dynamics shape availability and procurement cadence: hospital pharmacy procurement, whether managed in house or outsourced to third parties, demands bulk ordering and tight inventory control, while online channels-both B2B platforms and B2C platforms-support direct replenishment and flexible ordering. Retail pharmacy distribution, across chain and independent outlets, places emphasis on shelf visibility, end-user education, and point-of-sale compliance.

End-user segmentation drives product ergonomics and packaging. Ambulatory care settings and clinics, whether general or specialty, require devices optimized for throughput and varied administration contexts. Home care users necessitate simplified instructions and tamper-evident features to support safe self-administration. Hospitals, public and private, prioritize devices that integrate with institutional safety protocols and waste disposal systems. Capacity segmentation across 0.5 ml, 1 ml, 2 ml, and 5 ml volumes further influences needle gauge selection, dosing accuracy, and packaging footprint. Collectively, these segmentation layers guide manufacturers toward product portfolios that align with clinical workflows and procurement preferences across care settings.

Regional dynamics and growth levers across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping demand and localization strategies for safety syringes

Regional dynamics exert a strong influence on regulatory requirements, procurement preferences, and adoption velocity for retractable safety syringes. In the Americas, stakeholder focus centers on occupational safety metrics, large integrated health systems, and public procurement frameworks that favor evidence-backed devices and robust post-market surveillance. This region often prioritizes interoperability with existing waste management and sharps disposal protocols and shows a pronounced interest in devices that minimize training time and procedural variance.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization initiatives coexist with wide variance in procurement sophistication. In parts of Europe, stringent device regulations and strong health technology assessment processes encourage comprehensive clinical validation and lifecycle documentation. Middle Eastern markets emphasize rapid procurement cycles for high-volume tenders, while several African markets require cost-effective solutions and flexible distribution models that can accommodate variable logistics capacity.

Asia-Pacific encompasses diverse manufacturing hubs and high-growth healthcare infrastructures. Several countries in the region have become centers for advanced polymer manufacturing and precision molding, which supports localized production and rapid design iteration. Adoption in Asia-Pacific is often driven by national infection control priorities and large-scale vaccination programs that demand reliable, easy-to-deploy safety syringes. Across all regions, localization strategies, regulatory navigation, and targeted channel partnerships are essential to accelerate uptake and maintain supply continuity.

Competitive and company-level insights highlighting strategic moves, portfolio differentiation, and partnership models among leading retractable syringe manufacturers

Company-level dynamics in the retractable safety syringe space reflect a mixture of differentiation through mechanism innovation, scale efficiencies, and strategic partnerships. Leading manufacturers are investing in modular platforms that support both active and passive safety mechanisms, enabling faster adaptation to customer preferences and regulatory demands. Those that can demonstrate reproducible manufacturing quality, low defect rates, and strong post-market surveillance tend to secure larger institutional contracts and preferred supplier status.

Strategic moves often include co-development partnerships with clinically focused research centers and supply chain alliances that enhance raw material resilience. Companies emphasizing design-for-user acceptance-through ergonomic optimization and simplified activation-achieve higher clinician adoption rates and lower training costs. Meanwhile, manufacturers that offer transparent lifecycle data and digital traceability features position themselves favorably with procurement organizations prioritizing supplier accountability.

Mergers and targeted acquisitions continue to refine competitive positioning, particularly where established platform technologies can be combined with local manufacturing footprints to reduce lead times and tariff exposure. Smaller innovators with niche technology advantages may attract partnership or licensing interest from larger OEMs seeking to expand their safety device portfolios. Collectively, these company-level strategies underscore the importance of flexible manufacturing, regulatory preparedness, and customer-centric product development to sustain competitive advantage.

Actionable recommendations for industry leaders to optimize product development, supply chains, regulatory engagement, and go-to-market approaches for single-use syringes

Industry leaders should prioritize a coordinated set of actions to accelerate adoption while safeguarding supply resilience and regulatory compliance. First, align product development roadmaps to end-user preferences by investing in human factors research that validates usability across ambulatories, clinics, home care environments, and hospital workflows. Designing for ease of activation and minimizing additional training burden will materially improve clinician and patient acceptance.

Second, strengthen supply chain flexibility by diversifying sourcing across local and regional suppliers and building contingency capacity for critical subcomponents. Incorporate design-for-manufacturing decisions that reduce dependency on tariff-sensitive inputs and allow for rapid tooling transfers between manufacturing sites. Third, proactively engage with regulators and purchasers to share robust clinical evidence, post-market surveillance plans, and lifecycle data that demonstrate safety performance. Transparent regulatory engagement shortens approval timelines and enhances buyer confidence.

Fourth, tailor commercial strategies to distribution channel nuances; hospital pharmacy agreements require different value propositions than B2B online platforms or retail pharmacies. Consider pilot programs with large health systems to demonstrate operational benefits and collect real-world data that supports broader rollouts. Finally, explore partnerships with waste management providers and digital inventory platforms to deliver end-to-end solutions that address disposal safety and traceability, creating a stronger value proposition for institutional buyers.

Transparent research methodology explaining data sources, primary and secondary research, analytical frameworks, and validation processes used in this report

The research approach underpinning this report combined structured primary research with a rigorous secondary evidence synthesis to ensure balanced, validated insights. Primary inputs included interviews with procurement leads, clinical end users, regulatory specialists, and manufacturing executives to capture real-world perspectives on device performance, adoption barriers, and procurement criteria. These interviews were complemented by site visits and device usability assessments to ground technical observations in clinical workflows.

Secondary research incorporated regulatory guidance documents, standards for sharps protection, manufacturing best practices, and published clinical literature on device safety and user outcomes. Supply chain and trade policy analyses were informed by publicly available trade data, customs documentation trends, and industry white papers that describe tariff and localization impacts. Analytical frameworks applied in the study included segmentation mapping, cross-regional policy comparison, and scenario planning to evaluate supply disruption responses.

Validation steps included triangulating interview findings with procurement tender language and regulatory filings where available, and conducting peer review with subject-matter experts to ensure methodological robustness. The result is an evidence-based synthesis that balances strategic foresight with operationally relevant detail to support informed decisions across commercial, R&D, and supply chain functions.

Conclusion synthesizing implications for stakeholders and outlining immediate priorities to accelerate safe syringe adoption and operational resilience

This executive synthesis brings together the technical, regulatory, commercial, and operational dimensions that will define the near-term trajectory for retractable single-use safety syringes. Stakeholders should emerge from this analysis with clarity on where to focus design effort, how to prioritize sourcing and manufacturing investments, and what evidence will most convincingly accelerate adoption among clinical and procurement audiences.

Key priorities include strengthening human factors validation for diverse care settings, enhancing supply chain transparency to mitigate tariff and trade disruptions, and tailoring commercial models to distinct distribution channels and end users. Regional nuances-such as procurement sophistication in the Americas, regulatory complexity across Europe, Middle East & Africa, and manufacturing opportunity in Asia-Pacific-require localized strategies that nevertheless align with global quality and traceability standards.

Ultimately, success will depend on integrating device innovation with practical implementation plans that reduce training burden, simplify logistics, and provide demonstrable safety improvements. Organizations that combine technical excellence with proactive regulatory engagement and resilient sourcing will be best positioned to meet institutional needs and advance safer care delivery across settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Retractable Safety Syringe for Single Use Market, by Material

  • 8.1. Glass
  • 8.2. Plastic

9. Retractable Safety Syringe for Single Use Market, by Type

  • 9.1. Active Safety Syringe
    • 9.1.1. Air Powered
    • 9.1.2. Spring Loaded
  • 9.2. Passive Safety Syringe
    • 9.2.1. Plunger Retraction
    • 9.2.2. Sheathing Mechanism

10. Retractable Safety Syringe for Single Use Market, by Capacity

  • 10.1. 0.5 Ml
  • 10.2. 1 Ml
  • 10.3. 2 Ml
  • 10.4. 5 Ml

11. Retractable Safety Syringe for Single Use Market, by Distribution Channel

  • 11.1. Hospital Pharmacy
    • 11.1.1. In House
    • 11.1.2. Third Party
  • 11.2. Online
    • 11.2.1. B2B Platforms
    • 11.2.2. B2C Platforms
  • 11.3. Retail Pharmacy
    • 11.3.1. Chain Pharmacy
    • 11.3.2. Independent Pharmacy

12. Retractable Safety Syringe for Single Use Market, by End User

  • 12.1. Ambulatory Care
  • 12.2. Clinics
    • 12.2.1. General Clinics
    • 12.2.2. Specialty Clinics
  • 12.3. Home Care
  • 12.4. Hospitals
    • 12.4.1. Private
    • 12.4.2. Public

13. Retractable Safety Syringe for Single Use Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Retractable Safety Syringe for Single Use Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Retractable Safety Syringe for Single Use Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Retractable Safety Syringe for Single Use Market

17. China Retractable Safety Syringe for Single Use Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. Becton Dickinson and Company
  • 18.7. Gerresheimer AG
  • 18.8. Guangdong Haiou Medical Apparatus Co., Ltd.
  • 18.9. ICU Medical, Inc.
  • 18.10. Nipro Corporation
  • 18.11. Owen Mumford Limited
  • 18.12. Revolutions Medical Corporation
  • 18.13. Schott AG
  • 18.14. Terumo Corporation
  • 18.15. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY AIR POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY AIR POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY AIR POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SPRING LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SPRING LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SPRING LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PLUNGER RETRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PLUNGER RETRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PLUNGER RETRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SHEATHING MECHANISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SHEATHING MECHANISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SHEATHING MECHANISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 0.5 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 0.5 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 0.5 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 1 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 1 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 1 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 2 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 2 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 2 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 5 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 5 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY 5 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY IN HOUSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY IN HOUSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY IN HOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY THIRD PARTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY THIRD PARTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY THIRD PARTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY B2B PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY B2B PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY B2B PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY B2C PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY B2C PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY B2C PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 230. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 259. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 263. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY PASSIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 265. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 267. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 268. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 269. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 271. G7 RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 272. NATO RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. NATO RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. NATO RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE, BY ACTIVE SAFETY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 276. NATO RETRACTABLE SAFETY SYRINGE FOR SINGLE USE MARKET SIZE,